Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled date : 2021 - 09 - 30 save search
Kite Submits Supplemental Biologics License Application to U.S. Food and Drug Administration for Earlier Use of Yescarta® in Large B-cell Lymphoma
Published: 2021-09-30 (Crawled : 23:00) - biospace.com/
GILD | $66.93 -0.57% -0.55% 470
|
Health Technology
|
| O: 0.38%
H: 0.5%
C: -1.91%
food drug license t-cell
ImmixBio Announces FDA Orphan Drug Designation for IMX-110 for the Treatment of Soft Tissue Sarcoma
Published: 2021-09-30 (Crawled : 19:00) - biospace.com/
IMMX | $2.5 -2.72% -3.01% 120
|
| Email alert
Add to watchlist
treatment fda orphan drug drug designation soft tissue
GigaGen Licenses ProteoNic’s 2G UNicTM Technology Platform for High Yield Production of GigaGen’s Mono- and Polyclonal Antibody Drug Candidates
Published: 2021-09-30 (Crawled : 17:00) - biospace.com/
GRFS | $6.58 -2.95% -2.88% 580
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -2.01%
antibody drug license technology
Opioid Fight Clocks Another Win as Drug Distributors Reach Settlements
Published: 2021-09-30 (Crawled : 15:00) - biospace.com/
JNJ | News | $144.77 0.22% 0.4% 130K
|
Health Technology
|
| O: 0.38%
H: 0.46%
C: -1.91%
opioid drug
Global Roundup: Partnership Aims to Bolster Drug Discovery in Africa
Published: 2021-09-30 (Crawled : 15:00) - biospace.com/
JNJ | News | $144.77 0.22% 0.4% 130K
|
Health Technology
|
| O: 0.38%
H: 0.46%
C: -1.91%
NCNA | $3.97 1.8% 6.02% 850
|
Health Technology
|
| O: -4.68%
H: 1.51%
C: -2.64%
IMMP | News | $2.26 -0.22% 1
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: -3.97%
partnership drug discovery drug africa
Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021
Published: 2021-09-30 (Crawled : 13:00) - globenewswire.com
SMMT A | $3.57 0.85% 1.12% 1.4M
|
Health Technology
|
| O: 1.45%
H: 4.69%
C: 2.24%
drug
TG Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Ublituximab as a Treatment for Patients with Relapsing Forms of Multiple Sclerosis
Published: 2021-09-30 (Crawled : 13:00) - biospace.com/
TGTX | $13.82 -1.29% -1.27% 2.7M
|
Health Technology
|
| O: 0.21%
H: 3.12%
C: -1.07%
multiple sclerosis food treatment drug sclerosis license
CNS Pharmaceuticals Doses First Group of Patients with Berubicin, an FDA-Designated Fast Track Drug Candidate, in the Potentially Pivotal Study for the Treatment of Glioblastoma Multiforme (GBM)
Published: 2021-09-30 (Crawled : 12:15) - prnewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.64%
H: 1.89%
C: -5.08%
CNSP A | $0.2044 -1.97% -1.02% 1.2K
|
Health Technology
|
| O: -3.75%
H: 3.9%
C: -3.25%
berubicin treatment fda potential fast track drug designation glioblastoma
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
SINT | $0.0373 62.88% 65.82% 100M
|
Health Technology
INVO | $1.82 139.47% 49.67% 1.4M
|
Health Technology
HOLO | $2.24 -5.49% 27.74% 7.7M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
SMFL | $0.485 19.37% 21.18% 2.4M
|
Manufacturing
RCAT | $1.42 26.79% 20.0% 510K
|
Information
SECO | $0.3659 -2.06% 18.82% 1.3M
|
Retail Trade
VIAO | $0.262 0.77% 16.03% 14M
|
Electronic Technology
SBOW | $30.01 -5.75% 14.93% 43
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.